eUltra 10k - Biofreedom Ultra

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

March 30, 2029

Conditions
Post Market Clinical Follow up (PMCF)
Interventions
DEVICE

Biofreedom Ultra

The BioFreedomTM Ultra CoCr DCS is a combination product consisting of two key components: the cobalt chromium stent platform coated abluminally with the active ingredient BA9TM (polymer and carrier free) and the delivery system.

Trial Locations (1)

Unknown

RECRUITING

Royal Bournemouth hospital, Bournemouth

All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

Biosensors Europe SA

INDUSTRY